Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

| More on:
A cannabis plant grows.

Source: Getty Images

Canadian cannabis companies with high growth potential are down to two following huge financial losses of major players in recent years. If you plan to invest in cheap weed stocks right now, the choice is between Tilray Brands (TSX:TLRY) and Canopy Growth (TSX:WEED) only.

Interestingly, both stocks are out of the gate running in 2023. Tilray has advanced 17.2% to $4.33 from year-end 2022, while Canopy Growth is trending higher at $3.49 (+15.6% year to date). While the companies patiently await the federal legalization of marijuana in the U.S., they are making moves to achieve profitability through other avenues.

A new path to profitability

Tilray is a pioneer in cannabis research, cultivation, and distribution. Besides North America (U.S. and Canada), the $2.7 billion cannabis-lifestyle and consumer packaged goods company operates in Australia, Europe, and Latin America. On the TSX, the stock belongs in the healthcare sector under the drug manufacturing industry.

In Q2 fiscal 2023 (three months ended November 30, 2022), the net loss reached US$61.63 million compared to the US$5.79 million net income in Q2 fiscal 2022. Despite the loss, management remains upbeat and happy with the leadership position in Canada (8.3% market share).

Moreover, the US$11.2 million Adjusted EBITDA (earnings before interest, taxes, depreciation, and appreciation) marks 15 consecutive quarters of positive adjusted EBITDA. In the same quarter, gross profit and Cannabis gross profit rose 22% and 37% year over year to US$40.1 million and US$18.6 million, respectively.

Management is adapting to the evolving retail environment by removing costs and driving efficiencies across the platform in supply chain, procurement, packaging, and labour. Its Chairman and CEO, Irwin D. Simon, said, “During the second quarter, Tilray Brands took decisive, effective actions to manage operating cash flow.” There’s a focus too on accretive acquisitions and a path to long-term profitability.

More importantly, Simon said Tilray is not sitting back and waiting for the legalization of cannabis at the federal level in the US. Management sees strong growth potential in the alcohol business and plans to acquire more alcohol properties. It now owns Montauk Brewing Co. in New York and SweetWater Brewing Co., America’s 10th largest craft brewer.

Long-term market opportunity

Canopy Growth, the acknowledged early mover in Canada, went into a tailspin after showing solid growth potential in 2018 and 2019. Instead of significant earnings, the losses of this $1.76 billion cannabis producer mounted over the years, and its promise of sustained return on shareholder capital has yet to materialize.

In Q2 fiscal 2023, the financial results are the same. The net revenue declined 10% to $117.9 million versus Q2 fiscal 2022 following divestments from the Canadian retail cannabis business. Notably, the net loss in the same quarter widened by 1,320% year over year to $231.91 million.

Its CEO, David Klein, said, “The divestiture of our Canadian retail business marks an important step forward on our path to profitability and furthers Canopy Growth’s focus on generating revenue growth in the Canadian market.” Constellation Brands has a 36.8% ownership stake in Canopy, and the alcoholic beverage giant still sees a long-term market opportunity.

Patience is required

Whether you buy Tilray or Canopy Growth, you have to be patient. Fortune Business Insights estimates the global cannabis market to grow at a compounded annual rate of 32% until 2028 and be worth around US$198 billion.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Brands. The Motley Fool has a disclosure policy.

More on Cannabis Stocks

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Are Cannabis Stocks Still a Thing in 2023?

The whole question of whether cannabis stocks are still relevant in 2023 is an interesting one. Here's my take on…

Read more »

A cannabis plant grows.
Cannabis Stocks

Why Canopy Growth Stock Fell 72% Last Year

Canopy Growth stock is a beaten-up cannabis giant that is trading at a discount compared to historical multiples. But is…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is SNDL Stock a Buy in January 2023?

SNDL is among the worst-performing cannabis stocks in the last three years. But is SNDL stock a buy right now?

Read more »

a person watches a downward arrow crash through the floor
Cannabis Stocks

Why Tilray Stock Fell Almost 60% in 2022

Tilray is a Canadian cannabis stock that is down 93% from all-time highs. Let's see if TLRY stock is a…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

The Single Best Pot Stock to Buy in December 2022

Canopy Growth Corp. (TSX:WEED) is still my favourite pot stock to snatch up in the final days of December 2022.

Read more »